Literature DB >> 19968806

The effect of a target controlled infusion of propofol on predictability of recovery from anesthesia in children.

Jon McCormack1, Disha Mehta, Kawshala Peiris, Guy Dumont, Parry Fung, Joanne Lim, J Mark Ansermino.   

Abstract

BACKGROUND: Emergence following termination of a general anesthetic depends on the effect site concentration (C(e)) of the drug declining to an awakening value (C(e)-awake). C(e)-awake has been described in adults, but is unknown in children.
OBJECTIVES: To determine C(e)-awake in children following a target-controlled infusion (TCI) of propofol and to assess a C(e)-driven TCI system's ability to predict times to emergence from anesthesia.
METHODS: Subjects undergoing elective surgery, aged 3 months to <10 years were recruited into three age-stratified groups. A target C(e) of 3-4 microg x ml(-1) was selected for induction and subsequently titrated to patient response and surgical stimulus. Preoperative acetaminophen, a remifentanil infusion and regional anesthesia were permitted for supplemental analgesia. State Entropy (SE) was monitored from induction to emergence. Emergence was defined as the time of first purposeful spontaneous movement (PSM). Time zero was defined as the end of propofol infusion. Based on a pilot study, a C(e)-awake of 1.9 microg x ml(-1) was chosen as the wake-up threshold used by the software to predict emergence times.
RESULTS: Data was collected for 90 of 104 recruited patients. PSM occurred at a mean (sd) C(e) of 2.0 (0.5) microg x ml(-1) and an SE of 79 (11). There were no differences between age groups. A wide variation in emergence time was observed, with a mean (sd) of 16.9 (7) min, and a trend to more rapid emergence in older subjects.
CONCLUSION: A predicted C(e)-awake of 2.0 microg x ml(-1) in children aged 3 months to <10 years was identified with the selected model. For expert users of propofol in children, during shorter surgical procedures, TCI predicted emergence times do not offer significant clinical advantages.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19968806     DOI: 10.1111/j.1460-9592.2009.03196.x

Source DB:  PubMed          Journal:  Paediatr Anaesth        ISSN: 1155-5645            Impact factor:   2.556


  5 in total

Review 1.  Propofol: a review of its role in pediatric anesthesia and sedation.

Authors:  Vidya Chidambaran; Andrew Costandi; Ajay D'Mello
Journal:  CNS Drugs       Date:  2015-07       Impact factor: 5.749

2.  A pharmacodynamic analysis of factors affecting recovery from anesthesia with propofol-remifentanil target controlled infusion.

Authors:  Bon-Nyeo Koo; Jeong-Rim Lee; Gyu-Jeong Noh; Jae-Hoon Lee; Young-Ran Kang; Dong-Woo Han
Journal:  Acta Pharmacol Sin       Date:  2012-07-30       Impact factor: 6.150

3.  The Effect of UGT1A9, CYP2B6 and CYP2C9 Genes Polymorphism on Propofol Pharmacokinetics in Children.

Authors:  Dimitrije Pavlovic; Ivana Budic; Tatjana Jevtovic Stoimenov; Dragana Stokanovic; Vesna Marjanovic; Marija Stevic; Milan Slavkovic; Dusica Simic
Journal:  Pharmgenomics Pers Med       Date:  2020-01-17

4.  The relationship between the effect-site concentration of propofol and sedation scale in children: a pharmacodynamic modeling study.

Authors:  Young-Eun Jang; Sang-Hwan Ji; Ji-Hyun Lee; Eun-Hee Kim; Jin-Tae Kim; Hee-Soo Kim
Journal:  BMC Anesthesiol       Date:  2021-09-09       Impact factor: 2.217

5.  Delayed emergence from propofol anesthesia in a patient with Lesch-Nyhan syndrome: A case report.

Authors:  Jungwon Lee; Sung Mee Jung; Sungmin Jeon
Journal:  Medicine (Baltimore)       Date:  2020-08-21       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.